Nuveen Asset Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,092
| Closed | -$351K | – | 3352 |
|
|
2023
Q3 | $351K | Sell |
7,092
-46
| -0.6% | -$2.28K | ﹤0.01% | 2941 |
|
|
2023
Q2 | $558K | Buy |
7,138
+601
| +9% | +$47K | ﹤0.01% | 2878 |
|
|
2023
Q1 | $592K | Sell |
6,537
-505
| -7% | -$45.7K | ﹤0.01% | 2766 |
|
|
2022
Q4 | $831K | Sell |
7,042
-638
| -8% | -$75.3K | ﹤0.01% | 2754 |
|
|
2022
Q3 | $1.39M | Sell |
7,680
-62
| -0.8% | -$11.3K | ﹤0.01% | 2577 |
|
|
2022
Q2 | $694K | Buy |
7,742
+4,228
| +120% | +$379K | ﹤0.01% | 2932 |
|
|
2022
Q1 | $613K | Buy |
3,514
+26
| +0.7% | +$4.54K | ﹤0.01% | 2955 |
|
|
2021
Q4 | $1.15M | Sell |
3,488
-286
| -8% | -$94.2K | ﹤0.01% | 2813 |
|
|
2021
Q3 | $2.08M | Sell |
3,774
-83
| -2% | -$45.8K | ﹤0.01% | 2657 |
|
|
2021
Q2 | $1.75M | Sell |
3,857
-479
| -11% | -$217K | ﹤0.01% | 2775 |
|
|
2021
Q1 | $2.33M | Buy |
4,336
+883
| +26% | +$475K | ﹤0.01% | 2544 |
|
|
2020
Q4 | $3.05M | Buy |
3,453
+171
| +5% | +$151K | ﹤0.01% | 2298 |
|
|
2020
Q3 | $2.08M | Buy |
+3,282
| New | +$2.08M | ﹤0.01% | 2365 |
|